Equities research analysts expect that Waters Co. (NYSE:WAT) will announce earnings of $1.73 per share for the current fiscal quarter, Zacks reports. Six analysts have provided estimates for Waters’ earnings, with estimates ranging from $1.69 to $1.77. Waters posted earnings of $1.59 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 8.8%. The firm is scheduled to report its next earnings report before the market opens on Tuesday, April 23rd.
On average, analysts expect that Waters will report full-year earnings of $9.35 per share for the current year, with EPS estimates ranging from $9.27 to $9.45. For the next year, analysts anticipate that the firm will post earnings of $10.61 per share, with EPS estimates ranging from $10.23 to $11.15. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that follow Waters.
Waters (NYSE:WAT) last issued its quarterly earnings data on Wednesday, January 23rd. The medical instruments supplier reported $2.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.64 by $0.23. Waters had a return on equity of 34.18% and a net margin of 24.54%. The business had revenue of $715.00 million during the quarter, compared to analyst estimates of $702.74 million. During the same period in the prior year, the company posted $2.51 EPS. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year.
A number of equities analysts have issued reports on WAT shares. Zacks Investment Research lowered Waters from a “buy” rating to a “hold” rating in a research note on Monday, January 7th. BTIG Research increased their price target on Waters to $260.00 and gave the company a “buy” rating in a research note on Thursday, January 24th. Barclays reaffirmed a “hold” rating and set a $200.00 price target on shares of Waters in a research note on Friday, January 25th. Bank of America raised Waters from an “underperform” rating to a “neutral” rating in a research note on Thursday, January 3rd. Finally, Needham & Company LLC started coverage on Waters in a research note on Wednesday, January 2nd. They set a “hold” rating and a $177.00 price target for the company. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $208.99.
Shares of WAT stock opened at $239.58 on Friday. Waters has a 12-month low of $167.93 and a 12-month high of $255.21. The company has a market capitalization of $16.95 billion, a P/E ratio of 28.90, a price-to-earnings-growth ratio of 2.46 and a beta of 1.19. The company has a debt-to-equity ratio of 0.73, a current ratio of 5.93 and a quick ratio of 5.28.
In other news, SVP Mark T. Beaudouin sold 27,848 shares of the firm’s stock in a transaction on Friday, January 25th. The stock was sold at an average price of $225.36, for a total transaction of $6,275,825.28. Following the completion of the sale, the senior vice president now directly owns 2,796 shares of the company’s stock, valued at approximately $630,106.56. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Terrence P. Kelly sold 2,006 shares of the firm’s stock in a transaction on Monday, March 11th. The stock was sold at an average price of $239.69, for a total value of $480,818.14. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 105,032 shares of company stock valued at $24,284,760. 0.98% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Athena Capital Advisors LLC bought a new stake in shares of Waters during the 4th quarter worth $28,000. Rockland Trust Co. bought a new stake in shares of Waters during the 4th quarter worth $38,000. Reilly Financial Advisors LLC lifted its holdings in shares of Waters by 334.8% in the fourth quarter. Reilly Financial Advisors LLC now owns 200 shares of the medical instruments supplier’s stock valued at $38,000 after purchasing an additional 154 shares in the last quarter. Lindbrook Capital LLC purchased a new stake in shares of Waters in the fourth quarter valued at $41,000. Finally, Massey Quick Simon & CO. LLC purchased a new stake in shares of Waters in the first quarter valued at $43,000. 95.90% of the stock is owned by institutional investors and hedge funds.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Further Reading: How do buyers and sellers choose a strike price?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.